Cutler Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,600
Closed -$24K 5188
2020
Q1
$24K Buy
4,600
+1,300
+39% +$245K ﹤0.01% 2188
2019
Q4
$42K Buy
3,300
+2,700
+450% +$487K ﹤0.01% 1745
2019
Q3
$3K Sell
600
-23,600
-98% -$3.84M ﹤0.01% 3412
2019
Q2
$548K Buy
24,200
+17,300
+251% +$2.4M 0.05% 331
2019
Q1
$17K Sell
6,900
-23,000
-77% -$3.33M ﹤0.01% 2170
2018
Q4
$50K Buy
29,900
+16,200
+118% +$2.66M ﹤0.01% 1474
2018
Q3
$125K Sell
13,700
-7,600
-36% -$1.4M 0.01% 1077
2018
Q2
$86K Buy
21,300
+6,500
+44% +$1.04M 0.01% 1255
2018
Q1
$52K Sell
14,800
-22,300
-60% -$3.74M ﹤0.01% 1645
2017
Q4
$69K Sell
37,100
-7,800
-17% -$1.4M ﹤0.01% 1636
2017
Q3
$427K Sell
44,900
-43,200
-49% -$10M 0.02% 733
2017
Q2
$1.28M Buy
88,100
+32,100
+57% +$7.54M 0.05% 336
2017
Q1
$1.03M Sell
56,000
-88,100
-61% -$20.5M 0.04% 367
2016
Q4
$458K Buy
144,100
+18,400
+15% +$3.81M 0.02% 741
2016
Q3
$621K Sell
125,700
-17,500
-12% -$4.28M 0.03% 512
2016
Q2
$692K Buy
143,200
+45,400
+46% +$10.5M 0.04% 430
2016
Q1
$475K Buy
97,800
+8,700
+10% +$2.49M 0.03% 547
2015
Q4
$1.41M Buy
+89,100
New +$26.5M 0.08% 244

Other funds holding AGN

Cutler Group's AGN Position: Q2 2020 in Review

Cutler Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,293 shares — an estimated $228K sold.

Cutler Group first reported a position in AGN in Q4 2015 and held it in 16 quarters. The position peaked at $23.3M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cutler Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 1,293 Allergan plc shares in Q2 2020, an estimated $228K.
  • Cutler Group first reported a position in Allergan plc in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Allergan plc position peaked at $23.3M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.